Mody, Lona
Griffith, Kent A
Jones, Rochelle D.
Stewart, Abigail
Ubel, Peter A.
Jagsi, Reshma http://orcid.org/0000-0001-6562-1228
Funding for this research was provided by:
National Institutes of Health (5 RO1 HL 101997)
Article History
Received: 29 September 2020
Accepted: 22 December 2020
First Online: 19 January 2021
Compliance with Ethical Standards
:
: Dr. Jagsi has stock options as compensation for her advisory board role in Equity Quotient, a company that evaluates culture in health care companies; she has received personal fees from Amgen and Vizient and grants for unrelated work from the National Institutes of Health, the Doris Duke Foundation, the Greenwall Foundation, the Komen Foundation, and Blue Cross Blue Shield of Michigan for the Michigan Radiation Oncology Quality Consortium. She has a contract to conduct an investigator-initiated study with Genentech. She has served as an expert witness for Sherinian and Hasso and Dressman Benzinger LaVelle. She is an uncompensated founding member of TIME’S UP Healthcare and a member of the Board of Directors of ASCO. Dr. Ubel was supported by grants from the NIH and from the Robert Wood Johnson Foundation (Investigator Award in Health Policy Research). Dr. Mody was supported by grants from the NIH, VA, AHRQ and from the Dan and Betty Kahn Foundation.
Free to read: This content has been made available to all.